Skip to content
OpenCapital
Get started

Dogwood Therapeutics DWTX Q4 2025 Annual earnings

Reported March 18, 2026

Diluted EPS-$0.26Beat by $0.60
EPS estimate-$0.86

Next report

Aug 12, 2026 (In 3 weeks)
EPS estimate-$0.13

Financials

Q4 2025

Income statement

See full
Operating income-$3.8M+49.5%
Net income-$3.8M+51.1%

Balance sheet

See full
Cash & equivalents$6.5M-56.1%
Total debt$162.6K-20.5%
Total equity$74.9M+840%
Total assets$90.2M-4.4%

Cash flow

See full
Operating cash flow-$3.6M+40.7%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$123.67M+188%
Enterprise value$117.31M+314%

Returns & leverage

See full
Debt / equity0×—
Current ratio2.8×-2.5×

Versus estimates

Diluted EPS

Q1 2026-$0.15Beat by $0.07
Q4 2025-$0.26Beat by $0.60
Q3 2025-$8.20Miss by $6.97Q2 2025-$1.99Miss by $0.73Q1 2025-$4.21Miss by $3.44Q4 2024-$5.90Miss by $4.54

Ask the moment Dogwood Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Dogwood Therapeutics report Q4 2025 earnings?
Dogwood Therapeutics (DWTX) reported Q4 2025 earnings on March 18, 2026.
What were Dogwood Therapeutics's Q4 2025 revenue and EPS?
Dogwood Therapeutics reported diluted EPS of $-0.26 for Q4 2025.
Did Dogwood Therapeutics beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.86 by $0.60.
How did Dogwood Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 95.6% from $-5.90.
Where can I find Dogwood Therapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-029992) and the 10-K periodic report (0001104659-26-031061) directly on SEC EDGAR. The filing index links above go to sec.gov.